The Pulse
MegaRobo raises nearly $200 million for physical AI systems
MegaRobo raised nearly US$200 million in a financing round joined by the Oman Investment Authority. The company plans to invest in core technology and expand its AI for Science business globally.

MegaRobo Technologies has raised nearly US$200 million from investors including the Oman Investment Authority to develop systems that connect AI with physical experiments. The financing round also included new investor CMB International and existing backers Asia Investment Capital, Granite Asia and Sinovation Ventures, the company said in a November 19 release.
Source prnewswire.com
MegaRobo plans to use the funding for core technology, global expansion of its AI for Science business and infrastructure for AI in complex physical environments. The Oman Investment Authority is the sovereign wealth fund of the Sultanate of Oman.
Funding history
The company said it has now raised approximately US$600 million across multiple financing rounds. That total includes a nearly US$300 million Series C round co-led by Goldman Sachs Alternatives, Asia Investment Capital and Granite Asia.
The earlier round also included Pavilion Capital, part of Temasek's Seviora Group. MegaRobo named Sinovation Ventures, Joy Capital and MPCi as long-term investors, and WuXi AppTec and Bosch Ventures as earlier industry investors.
Connecting AI to experiments
MegaRobo is developing a technology foundation that links AI models and agents with software, scientific instruments, robotics, automation and feedback from physical systems. Its platform, called One Intelligence Stack, also brings together data and workflows.
The company is applying the approach to scientific discovery and pharmaceutical research and development. Its AI for Science infrastructure combines scientific computing and experimental execution with data and R&D decision-making.
MegaRobo says its products and technologies have reached more than 500 customers, including pharmaceutical companies, drug discovery organizations, biotechnology companies and research institutions. The systems support stages of discovery and development ranging from early research and target and mechanism discovery to drug screening and candidate optimization.
At Megalaxy Lab, researchers and AI agents can configure experiments, send them to automated laboratory systems, track their execution and receive structured, machine-readable results. The company says Megalaxy Lab has served more than 200 customers.
Protein design challenge
MegaRobo has also launched Poreva Open with industry partners including Tencent Cloud and Twist Bioscience. The global AI protein design competition accepts all models and technical approaches, and Megalaxy Lab is to provide wet-lab validation for more than 10,000 protein design sequences.
The competition is open to teams from academic institutions, research organizations, university laboratories, biotechnology companies and AI companies worldwide. All submissions are to undergo standardized, double-blind experimental evaluation at Megalaxy Lab. Results and experimental data, including data on unsuccessful designs, are to be made public after the competition, subject to intellectual property and compliance requirements.
The inaugural competition has five challenges. The first three focus on EGFR, TNF-α and GLP-1R, with two additional challenges to be announced in the second round; selected candidate molecules may advance to further testing in biological models, including organoids.
The competition offers US$250,000 in cash prizes (RMB 1.7 million). Megalaxy Lab will also provide US$150,000 (RMB 1 million) in wet-lab validation credits at no cost to participants. The published schedule calls for experimental validation by March 2027 and publication of results and experimental data in April 2027.
Sources
Related stories
- Agile Robots raises $500 million at $8.5 billion valuation
- SK hynix earns LPDDR5X safety certification and a cybersecurity certification
- RIKEN starts AI-for-science initiative with shared platform plan
- Microsoft Open-Sources RetroChimera for Molecule Synthesis Planning
- CloudBackend raises €6.6 million for AI application infrastructure